Microbiome factors in HPV-driven carcinogenesis and cancers.
作者信息
Lin Daniel, Kouzy Ramez, Abi Jaoude Joseph, Noticewala Sonal S, Delgado Medrano Andrea Y, Klopp Ann H, Taniguchi Cullen M, Colbert Lauren E
机构信息
Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
出版信息
PLoS Pathog. 2020 Jun 4;16(6):e1008524. doi: 10.1371/journal.ppat.1008524. eCollection 2020 Jun.
Abstract
摘要
相似文献
1
Microbiome factors in HPV-driven carcinogenesis and cancers.
PLoS Pathog. 2020 Jun 4;16(6):e1008524. doi: 10.1371/journal.ppat.1008524. eCollection 2020 Jun.
2
The human papillomavirus (HPV)-related cancer biology: An overview.
Biomed Pharmacother. 2018 Oct;106:1537-1556. doi: 10.1016/j.biopha.2018.06.149. Epub 2018 Jul 26.
3
p16 in HPV-associated cancers.
Oncotarget. 2013 Nov;4(11):1864-5. doi: 10.18632/oncotarget.1523.
4
MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
PLoS Pathog. 2020 Jun 18;16(6):e1008624. doi: 10.1371/journal.ppat.1008624. eCollection 2020 Jun.
5
[The role of viruses in the etiology of bladder cancer].
Urologiia. 2016 Aug(3):100-103.
6
Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
PLoS Pathog. 2020 Apr 16;16(4):e1008468. doi: 10.1371/journal.ppat.1008468. eCollection 2020 Apr.
7
Targeting activated Rho proteins: a new approach for treatment of HPV and other virus-related cancers?
Expert Rev Anticancer Ther. 2011 Jul;11(7):973-6. doi: 10.1586/era.11.86.
8
The retinoblastoma protein/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma.
Histopathology. 2011 Feb;58(3):433-9. doi: 10.1111/j.1365-2559.2011.03762.x. Epub 2011 Feb 16.
9
[Advances in Understanding Carcinogenetic Mechanisms of the Human Papillomavirus and Vaccines Based on Virus-like Particles].
Bing Du Xue Bao. 2015 Mar;31(2):180-6.
10
Next generation sequencing and its applications in HPV-associated cancers.
Oncotarget. 2017 Jan 31;8(5):8877-8889. doi: 10.18632/oncotarget.12830.
引用本文的文献
1
Degradation of Resistant α-1,4-glucan by Vaginal Gardnerella Species is Associated with Bacterial Vaginosis.
Curr Microbiol. 2025 Sep 2;82(10):487. doi: 10.1007/s00284-025-04459-9.
2
Probiotics: A New Approach for the Prevention and Treatment of Cervical Cancer.
Probiotics Antimicrob Proteins. 2025 Feb 14. doi: 10.1007/s12602-025-10479-5.
3
The Natural History of Cervical Cancer and the Case for MicroRNAs: Is Human Papillomavirus Infection the Whole Story?
Int J Mol Sci. 2024 Dec 3;25(23):12991. doi: 10.3390/ijms252312991.
4
Targeting CDCP1 boost CD8+ T cells-mediated cytotoxicity in cervical cancer via the JAK/STAT signaling pathway.
J Immunother Cancer. 2024 Oct 24;12(10):e009416. doi: 10.1136/jitc-2024-009416.
5
Cervical cancer microbiome analysis: comparing HPV 16 and 18 with other HPV types.
Sci Rep. 2024 Sep 24;14(1):22014. doi: 10.1038/s41598-024-73317-8.
6
Mechanisms of crosstalk between the oropharyngeal microbiome and human papillomavirus in oropharyngeal carcinogenesis: a mini review.
Front Oncol. 2024 Aug 15;14:1425545. doi: 10.3389/fonc.2024.1425545. eCollection 2024.
7
Unveiling the multifaceted realm of human papillomavirus: a comprehensive exploration of biology, interactions, and advances in cancer management.
Front Immunol. 2024 Aug 8;15:1430544. doi: 10.3389/fimmu.2024.1430544. eCollection 2024.
8
Altered vaginal cervical microbiota diversity contributes to HPV-induced cervical cancer inflammation regulation.
PeerJ. 2024 Jun 12;12:e17415. doi: 10.7717/peerj.17415. eCollection 2024.
9
Cervical cancer subtype identification and model building based on lipid metabolism and post-infection microenvironment immune landscape.
Heliyon. 2024 May 4;10(9):e30746. doi: 10.1016/j.heliyon.2024.e30746. eCollection 2024 May 15.
10
Human papillomavirus and cervical cancer in the microbial world: exploring the vaginal microecology.
Front Cell Infect Microbiol. 2024 Jan 25;14:1325500. doi: 10.3389/fcimb.2024.1325500. eCollection 2024.
本文引用的文献
1
The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL.
Nature. 2019 Oct;574(7777):264-267. doi: 10.1038/s41586-019-1608-2. Epub 2019 Oct 2.
2
Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.
Gynecol Oncol. 2019 Nov;155(2):237-244. doi: 10.1016/j.ygyno.2019.09.002. Epub 2019 Sep 26.
3
The Host-Microbe Interplay in Human Papillomavirus-Induced Carcinogenesis.
Microorganisms. 2019 Jul 13;7(7):199. doi: 10.3390/microorganisms7070199.
4
Altered diversity and composition of the gut microbiome in patients with cervical cancer.
AMB Express. 2019 Mar 23;9(1):40. doi: 10.1186/s13568-019-0763-z.
5
Compositional and Functional Differences between Microbiota and Cervical Carcinogenesis as Identified by Shotgun Metagenomic Sequencing.
Cancers (Basel). 2019 Mar 5;11(3):309. doi: 10.3390/cancers11030309.
6
Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions.
mBio. 2019 Feb 19;10(1):e02785-18. doi: 10.1128/mBio.02785-18.
7
The Performance of an Oral Microbiome Biomarker Panel in Predicting Oral Cavity and Oropharyngeal Cancers.
Front Cell Infect Microbiol. 2018 Aug 3;8:267. doi: 10.3389/fcimb.2018.00267. eCollection 2018.
8
Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women.
Sci Rep. 2018 May 15;8(1):7593. doi: 10.1038/s41598-018-25879-7.
9
High-resolution microbiome profiling uncovers , , and associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation.
Oncotarget. 2017 Sep 7;8(67):110931-110948. doi: 10.18632/oncotarget.20677. eCollection 2017 Dec 19.
10
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2.
Zotero 插件